Bactericidal activity of the fluoroquinolone DU-6859a alone and in combination with other antimicrobial agents against multiresistant enterococci

Diagnostic Microbiology and Infectious Disease

Volumn 26, Issue 2, 1996, Pages 79-85

  Korten, Volkan ^a   Erdem, Ilknur ^a   Murray, Barbara E ^b  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANIC ACID; IMIPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SITAFLOXACIN; SULBACTAM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; ENTEROCOCCUS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIBIOTICS, ANTITUBERCULAR; CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASES, TYPE II; DRUG ANTAGONISM; DRUG COMBINATIONS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; DRUG SYNERGISM; ENTEROCOCCUS; FLUOROQUINOLONES; GENTAMICINS; LACTAMS; MICROBIAL SENSITIVITY TESTS; NOVOBIOCIN; QUINOLONES; RIFAMPIN; VARIATION (GENETICS);

EID: 0030266627     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(96)00197-6     Document Type: Article

References (24)

1. Brandt CM, Rouse MS, Tallan BM, et al. (1994) Effective treatment of multidrug resistant enterococcl experimental endocarditis with combinations of cell-wall active agents. In Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Orlando, FL, (abst B75), p. 150.
2. Cercenado E, Eliopoulos GM, Wennersten CB, and Moellering RC, Jr. (1992) Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococci. Antimicrob Agents Chemother 36:2201-2203.
3. Eliopoulos GM and Moellering RC, Jr. (1991) Antimicrobial combinations. In Antibiotics in Laboratory Medicine. Ed, V Lorian. Baltimore, MD: Williams & Wilkins, pp. 432-492.
4. Fernandez-Guerrero M, Rouse MS, Henry NK, Geraci JE, and Wilson WR (1987) In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis. Antimicrob Agents Chemother 31:430-433.
5. Fraimow HS and Venuti E (1992) Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin aginst vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium. Antimicrob Agents Chemother 36:1563-1566.
6. French P, Venuti E, and Fraimow HS (1993) In vitro activity of novobiocin against multiresistant strains of Enterococcus faecium. Antimicrob Agents Chemother 37:2736-2739.
7. Gutmann L, Al-Obeid S, Billot-Klein D, Guerrierez ML, and Collatz E (1994) Synergy and resistance to synergy between beta-lactam antibiotics and glycopeptides against glycopeptide-resistant strains of Enterococcus faecium. Antimicrob Agents Chemother 38:824-829.
8. Handwerger S, Raucher B, Altarac D, et al. (1993) Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin and gentamicin. Clin Infect Dis 16:750-755.
9. Korten V, Huang WM, and Murray BE (1994a) Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis. Antimicrob Agents Chemother 38:2091-2094.
10. Korten V and Murray BE (1993) The nosocomial transmission of enterococci. Curr Opinion Infect Dis 6:498-505.
11. Korten V, Tomayko JF, and Murray BE (1994b) Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against Gram-positive cocci. Antimicrob Agents Chemother 38:611-615.
12. Landman D, Mobarakai NK, and Quale JM (1993) Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin. Antimicrob Agents Chemother 37:1904-1908.
13. Mainardi JL, Gutmann L, Acar JF, and Goldstein FW (1995) Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis. Antimicrob Agents Chemother 39: 1984-1987.
14. Moellering RC, Jr and Wennersten C (1983) Therapeutic potential of rifampin in enterococcal infections. Rev Infect Dis 5:528-532.
15. Moody JA, Peterson LR, and Gerding DN (1985) In vitro activity of ciprofloxacin combined with azlocillin. Antimicrob Agents Chemother 28:849-850.
16. Nakashima M, Uematsu T, Nakano M, Kosuge K, Tanaka M, and Hakusui H (1993) Pharmacokinetics and safety investigation of a new fluoroquinolone, DU-6859a in healthy male volunteers. In Program and Abstracts of the 33rd Interescience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, LA, (abst 1004).
17. Noskin GA, Mehl P, and Warren JR (1993) Bactericidal activity of the fluoroquinolone WIN 57273 against high-level gentamicin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 37:2470-2473.
18. Pearson RD, Steigbigel RT, Davis HT, and Chapman SW (1980) Method for reliable determination of minimal lethal antibiotic concentrations. Antimicrob Agents Chemother 18:699-708.
19. Perri MB, Chow JW, and Zervos MJ (1993) In vitro activity of sparfloxacin and clinafloxacin against multidrug-resistant enterococci. Diagn Microbiol Infect Dis 17:151-155.
20. Schaberg DR, Culver DH, and Gaynes RP (1991) Major trends in the microbial etiology of nosocomial infection. Am J Med 91:72-75.
21. Schaberg DR, Dillon WI, Tarpenning MS, Robinson KA, Bradley SF, and Kauffman CA (1992) Increasing resistance of enterococci to ciprofloxacin. Antimicrob Agents Chemother 36:2533-2535.
22. Shlaes DM, Etter L, and Gutman L (1991) Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamicm. Antimicrob Agents Chemother 35:776-779.
23. Torres C, Tenorio C, Lantero M, Gastanares MJ, and Baquero F (1993) High-level penicillin resistance and penicillin-gentamicin synergy in Enterococcus faecium. Antimicrob Agents Chemother 37:2427-2421.
24. Whitman MS, Pitsakis PG, Zausner A, et al. (1993) Antibiotic treatment of experimental endocarditis due to vancomycin-and ampicillin-resistant Enterococcus faecium. Antimicrob Agents Chemother 37:2069-2073.